Detalhe da pesquisa
1.
Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production.
Cell Mol Life Sci
; 81(1): 262, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38878186
2.
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors.
Int J Mol Sci
; 23(1)2021 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008589
3.
Macrophages in Renal Fibrosis.
Adv Exp Med Biol
; 1165: 285-303, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399970
4.
Transforming growth factor-ß signalling in renal fibrosis: from Smads to non-coding RNAs.
J Physiol
; 596(16): 3493-3503, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29781524
5.
Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects.
Biomaterials
; 288: 121730, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995622
6.
Inhibition of tumor invasion and metastasis by targeting TGF-ß-Smad-MMP2 pathway with Asiatic acid and Naringenin.
Mol Ther Oncolytics
; 20: 277-289, 2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33614911